Literature DB >> 24375814

Characterization of thoracic motor and sensory neurons and spinal nerve roots in canine degenerative myelopathy, a potential disease model of amyotrophic lateral sclerosis.

Brandie R Morgan1, Joan R Coates, Gayle C Johnson, G Diane Shelton, Martin L Katz.   

Abstract

Canine degenerative myelopathy (DM) is a progressive, adult-onset, multisystem degenerative disease with many features in common with amyotrophic lateral sclerosis (ALS). As with some forms of ALS, DM is associated with mutations in superoxide dismutase 1 (SOD1). Clinical signs include general proprioceptive ataxia and spastic upper motor neuron paresis in pelvic limbs, which progress to flaccid tetraplegia and dysphagia. The purpose of this study was to characterize DM as a potential disease model for ALS. We previously reported that intercostal muscle atrophy develops in dogs with advanced-stage DM. To determine whether other components of the thoracic motor unit (MU) also demonstrated morphological changes consistent with dysfunction, histopathologic and morphometric analyses were conducted on thoracic spinal motor neurons (MNs) and dorsal root ganglia (DRG) and in motor and sensory nerve root axons from DM-affected boxers and Pembroke Welsh corgis (PWCs). No alterations in MNs or motor root axons were observed in either breed. However, advanced-stage PWCs exhibited significant losses of sensory root axons, and numerous DRG sensory neurons displayed evidence of degeneration. These results indicate that intercostal muscle atrophy in DM is not preceded by physical loss of the motor neurons innervating these muscles, nor of their axons. Axonal loss in thoracic sensory roots and sensory neuron death suggest that sensory involvement may play an important role in DM disease progression. Further analysis of the mechanisms responsible for these morphological findings would aid in the development of therapeutic intervention for DM and some forms of ALS.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  SOD1; axon; dog; dorsal root ganglion; morphometry

Mesh:

Substances:

Year:  2013        PMID: 24375814      PMCID: PMC4096142          DOI: 10.1002/jnr.23332

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  42 in total

1.  Sensory nerve pathology in amyotrophic lateral sclerosis.

Authors:  T Heads; M Pollock; A Robertson; W H Sutherland; S Allpress
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

Review 2.  Cytopathology of amyotrophic lateral sclerosis.

Authors:  A Hirano
Journal:  Adv Neurol       Date:  1991

3.  Autosomal recessive adult-onset amyotrophic lateral sclerosis associated with homozygosity for Asp90Ala CuZn-superoxide dismutase mutation. A clinical and genealogical study of 36 patients.

Authors:  P M Andersen; L Forsgren; M Binzer; P Nilsson; V Ala-Hurula; M L Keränen; L Bergmark; A Saarinen; T Haltia; I Tarvainen; E Kinnunen; B Udd; S L Marklund
Journal:  Brain       Date:  1996-08       Impact factor: 13.501

4.  A compensatory subpopulation of motor neurons in a mouse model of amyotrophic lateral sclerosis.

Authors:  Anneliese M Schaefer; Joshua R Sanes; Jeff W Lichtman
Journal:  J Comp Neurol       Date:  2005-09-26       Impact factor: 3.215

5.  Generalised sensory system abnormalities in amyotrophic lateral sclerosis: a European multicentre study.

Authors:  K Pugdahl; A Fuglsang-Frederiksen; M de Carvalho; B Johnsen; P R W Fawcett; A Labarre-Vila; R Liguori; W A Nix; I S Schofield
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-07       Impact factor: 10.154

6.  Sensory involvement in the SOD1-G93A mouse model of amyotrophic lateral sclerosis.

Authors:  Yan Su Guo; Dong Xia Wu; Hong Ran Wu; Shu Yu Wu; Cheng Yang; Bin Li; Hui Bu; Yue Sheng Zhang; Chun Yan Li
Journal:  Exp Mol Med       Date:  2009-03-31       Impact factor: 8.718

7.  Genome-wide association analysis reveals a SOD1 mutation in canine degenerative myelopathy that resembles amyotrophic lateral sclerosis.

Authors:  Tomoyuki Awano; Gary S Johnson; Claire M Wade; Martin L Katz; Gayle C Johnson; Jeremy F Taylor; Michele Perloski; Tara Biagi; Izabella Baranowska; Sam Long; Philip A March; Natasha J Olby; G Diane Shelton; Shahnawaz Khan; Dennis P O'Brien; Kerstin Lindblad-Toh; Joan R Coates
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-02       Impact factor: 11.205

8.  Degenerative myelopathy in 18 Pembroke Welsh Corgi dogs.

Authors:  P A March; J R Coates; R J Abyad; D A Williams; D P O'Brien; N J Olby; J H Keating; M Oglesbee
Journal:  Vet Pathol       Date:  2009-03       Impact factor: 2.221

9.  Clinical characterization of a familial degenerative myelopathy in Pembroke Welsh Corgi dogs.

Authors:  Joan R Coates; Philip A March; Michael Oglesbee; Craig G Ruaux; Natasha J Olby; Roy D Berghaus; Dennis P O'Brien; John H Keating; Gary S Johnson; David A Williams
Journal:  J Vet Intern Med       Date:  2007 Nov-Dec       Impact factor: 3.333

10.  Amyotrophic lateral sclerosis with sensory neuropathy: part of a multisystem disorder?

Authors:  Jeremy D Isaacs; Andrew F Dean; Christopher E Shaw; Ammar Al-Chalabi; Kerry R Mills; P Nigel Leigh
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-07       Impact factor: 10.154

View more
  9 in total

1.  Electrical Impedance Myography in Dogs With Degenerative Myelopathy.

Authors:  Joseph B Kowal; Sarah A Verga; Sarbesh R Pandeya; Randall J Cochran; Julianna C Sabol; Seward B Rutkove; Joan R Coates
Journal:  Front Vet Sci       Date:  2022-05-27

2.  Variants within the SP110 nuclear body protein modify risk of canine degenerative myelopathy.

Authors:  Emma L Ivansson; Kate Megquier; Sergey V Kozyrev; Eva Murén; Izabella Baranowska Körberg; Ross Swofford; Michele Koltookian; Noriko Tonomura; Rong Zeng; Ana L Kolicheski; Liz Hansen; Martin L Katz; Gayle C Johnson; Gary S Johnson; Joan R Coates; Kerstin Lindblad-Toh
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-16       Impact factor: 11.205

3.  Changes in respiratory function in Pembroke Welsh Corgi dogs with degenerative myelopathy.

Authors:  Kanae Oyake; Yui Kobatake; Sanae Shibata; Hiroki Sakai; Miyoko Saito; Osamu Yamato; Kazuya Kushida; Sadatoshi Maeda; Hiroaki Kamishina
Journal:  J Vet Med Sci       Date:  2016-04-24       Impact factor: 1.267

4.  Cerebrospinal Fluid Levels of Phosphorylated Neurofilament Heavy as a Diagnostic Marker of Canine Degenerative Myelopathy.

Authors:  C M Toedebusch; M D Bachrach; V B Garcia; G C Johnson; M L Katz; G Shaw; J R Coates; M L Garcia
Journal:  J Vet Intern Med       Date:  2017-02-10       Impact factor: 3.333

5.  ATP13A2 missense variant in Australian Cattle Dogs with late onset neuronal ceroid lipofuscinosis.

Authors:  Isabelle Schmutz; Vidhya Jagannathan; Florian Bartenschlager; Veronika M Stein; Achim D Gruber; Tosso Leeb; Martin L Katz
Journal:  Mol Genet Metab       Date:  2019-03-27       Impact factor: 4.797

6.  Visual system pathology in a canine model of CLN5 neuronal ceroid lipofuscinosis.

Authors:  Grace Robinson Kick; Elizabeth J Meiman; Julianna C Sabol; Rebecca E H Whiting; Juri Ota-Kuroki; Leilani J Castaner; Cheryl A Jensen; Martin L Katz
Journal:  Exp Eye Res       Date:  2021-06-30       Impact factor: 3.770

7.  Intracerebroventricular gene therapy that delays neurological disease progression is associated with selective preservation of retinal ganglion cells in a canine model of CLN2 disease.

Authors:  Rebecca E H Whiting; Cheryl A Jensen; Jacqueline W Pearce; Lauren E Gillespie; Daniel E Bristow; Martin L Katz
Journal:  Exp Eye Res       Date:  2016-04-01       Impact factor: 3.467

8.  Grand Challenge Veterinary Neurology and Neurosurgery: Veterinary Neurology and Neurosurgery - Research for Animals and Translational Aspects.

Authors:  Andrea Tipold
Journal:  Front Vet Sci       Date:  2015-05-26

9.  Primary Postnatal Dorsal Root Ganglion Culture from Conventionally Slaughtered Calves.

Authors:  A Fadda; M Bärtschi; A Hemphill; H R Widmer; A Zurbriggen; P Perona; B Vidondo; A Oevermann
Journal:  PLoS One       Date:  2016-12-09       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.